COVID-19 Vaccine Likely in 2020

Vaccine for COVID-19 is likely to be developed in 2020, but production will only start by the end of 2021, said Sweden’s chief epidemiologist Dr Anders Tegnell.

In 2020, the COVID-19 may be developed, but its production will only start by the end of 2021, said Sweden’s chief epidemiologist Dr Anders Tegnell.

In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of COVID-19 Sweden's lockdown-lite, said: "To reach full herd immunity to stop the disease and may be get rid of the disease in the long term, by certain you need a vaccine.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘COVID-19 vaccine may be developed in 2020, but the production will start maybe by the end of 2021.’

He added people do get immunity from Covid-19. "We can tell this from four-five months of experience, and from our Swedish experience, we can say that we do not have a single person who has contracted the disease twice.

"There are very few reports, even internationally, people getting it more than once. We have a very strong system in Sweden, to identify if a person has disease twice," said Tegnell.

Explaining the aspect of immunity against the viral infection, Tegnell said that for how long the immunity will last, it has not been established yet; it may last for months and maybe for years.

COVID-19 Lockdown: Increase Family Time to Limit Your Child�s Screen Time
Want to keep your kids away from mobile phones? Spending quality time with family and playing a family game can limit your child's screen time while social distancing during the COVID-19 lockdown.

He insisted that herd immunity is a complicated matter, but already with levels of immunity of the population, which is much lower than the threshold of the herd immunity would affect the speed of the spread.

Citing the herd immunity in Stockholm, he added that at least 1/5th of the population in Stockholm is immune by now, and it's apparent from the decrease of spread of the infection. "This will cut down on the spread of the disease considerably," he added.

NASA Selects 3 Indian Firms to Make Low Cost COVID-19 Ventilator
NASA has selected three Indian companies to make a low-cost ventilator tailored for COVID-19 patients.

He added that COVID-19 will stay for a long time, which means there should be some kind of sustainable response, and part of this will be, of course, the number of immune people in the population.

Detailing the secondary rate of attack of disease, where a family member infects others in the family, Tegnell said: "We see a fair amount of spread within families.

How Could COVID-19 be Prevented from Invading a Host Cell?
Protease inhibitors or inhibitor cocktails that target SARS-CoV2 could potentially ward off future pandemics because of additional mutations in the S-protein priming sequence in coronaviruses.

"Lot of people get disease very mildly and you only catch them if you do PCR on them. From one case of severe disease you may have 70 to 80 people with mild disease. The number of people we do not recognize is very high."

Responding to the query, why no masks in Sweden, Tegnell said "We fairly know for certain that masks do not protect you from getting ill outside of the hospital, because the kind of mask you use will not stop the virus from entering your respiratory tract. It might have some effect on you of infecting other people when you are sick."

He added that in Sweden, people are told it is better to stay home when sick rather than wear the mask. "As many other countries we are quite hesitant about the level of evidence with a mask....There are also handling issues, you should know how to handle masks....In Sweden wearing a mask will cause more problems than benefits.

Source-IANS